Retinal Dystrophies
Information
- Disease name
- Retinal Dystrophies
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04123626 | Active, not recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene | October 7, 2019 | June 7, 2022 |
| NCT04945772 | Completed | Phase 2 | Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] | July 13, 2021 | January 18, 2024 |
| NCT01546181 | Completed | Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases | October 2010 | June 15, 2017 | |
| NCT02983305 | Completed | N/A | Optical Head-Mounted Display Technology for Low Vision Rehabilitation | June 26, 2017 | November 21, 2018 |
| NCT03763227 | Completed | Phase 2 | Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy | July 24, 2015 | August 29, 2019 |
| NCT03843840 | Completed | Dual Wavelength OCT | February 15, 2019 | October 21, 2020 | |
| NCT06162585 | Enrolling by invitation | Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study | December 8, 2023 | September 2027 | |
| NCT06455826 | Not yet recruiting | Phase 1 | MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) | June 2024 | November 2025 |
| NCT06319872 | Not yet recruiting | Phase 1 | The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration | April 15, 2024 | April 15, 2025 |
| NCT02014389 | Recruiting | Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer | December 1, 2013 | December 31, 2026 | |
| NCT05294978 | Recruiting | EyeConic: Qualification for Cone-Optogenetics | July 1, 2021 | December 2024 | |
| NCT05573984 | Recruiting | Natural History of PRPF31 Mutation-Associated Retinal Dystrophy | July 7, 2022 | April 30, 2027 | |
| NCT03853252 | Recruiting | N/A | iPS Cells of Patients for Models of Retinal Dystrophies | November 3, 2014 | November 2024 |
| NCT06177977 | Recruiting | N/A | SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs) | March 1, 2024 | December 2026 |
| NCT03592017 | Unknown status | N/A | Performance of Long-wavelength Autofluorescence Imaging | October 1, 2018 | July 30, 2022 |
| NCT04855045 | Unknown status | Phase 2/Phase 3 | An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. | March 23, 2021 | December 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D058499